Assurance in clinical trial designAnthony O’Hagan, Michael J. Campbell, John Stevens|Pharmaceutical Statistics|2005Cited by 293
A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fracturesSarah Davis, Neil Gittoes, Marrissa Martyn‐St James et al.|Health Technology Assessment|2016Cited by 79
Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysisJean Sanderson, Sarah Davis, Marrissa Martyn‐St James et al.|Bone|2016Cited by 76
Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential AnalysisMartin J. Brodie, John Stevens, S. Wroe et al.|Epilepsy & Behavior|2002Cited by 43
Bayesian decision procedures for dose‐escalation based on evidence of undesirable events and therapeutic benefitJohn Whitehead, Joanna Leadbetter, Yinghui Zhou et al.|Statistics in Medicine|2005Cited by 41